Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Placebo-controlled Phase III Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

NCT01357772 is registered in ClinicalTrials.gov with Andrea DeCensi as lead sponsor.

NCT NCT01357772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01357772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Placebo-controlled Phase III Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up
Lead sponsor
Andrea DeCensi
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 12, 2008
Completion date
December 31, 2028
Enrollment
500 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

atypical hyperplasia, breast neoplasms, carcinoma, intraductal, noninfiltrating, recurrence, local neoplasm